Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ankaferd Blood Stopper as a New Strategy to Avoid Early Complication After Transradial Coronary Angiography: A Randomized, Placebo-Controlled Clinical Trial

NCT02982733 is registered in ClinicalTrials.gov with Acibadem University as lead sponsor.

NCT NCT02982733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02982733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ankaferd Blood Stopper as a New Strategy to Avoid Early Complication After Transradial Coronary Angiography: A Randomized, Placebo-Controlled Clinical Trial
Lead sponsor
Acibadem University
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
December 31, 2017
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleed, hematoma, radial artery injury